1.73 USD
-0.04 (-2.26%)
1.7 USD
-0.03 (-1.73%)
ChartMill assigns a Buy % Consensus number of 77% to INMB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.36. This target is 209.54% above the current price.
INMB was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about INMB.
In the previous month the buy percentage consensus was at a similar level.
INMB was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-02 | Maxim Group | Maintains | Buy -> Buy |
| 2025-07-01 | ScotiaBank | Downgrade | Sector Outperform -> Sector Underperform |
| 2025-07-01 | BTIG | Downgrade | Buy -> Neutral |
| 2025-02-13 | Maxim Group | Maintains | Buy -> Buy |
| 2025-02-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-10-21 | Alliance Global Partners | Initiate | Buy |
| 2024-09-27 | Raymond James | Initiate | Outperform |
| 2024-08-22 | ScotiaBank | Initiate | Sector Outperform |
| 2023-06-01 | Baird | Initiate | Outperform |
| 2022-05-24 | BTIG | Maintains | Buy |
| 2022-05-24 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-04-21 | B. Riley FBR | Initiate | Buy |
INMUNE BIO INC / INMB FAQ
What is the average price target for INMUNE BIO INC (INMB) stock?
12 analysts have analysed INMB and the average price target is 5.36 USD. This implies a price increase of 209.54% is expected in the next year compared to the current price of 1.73.
How do analysts rate INMUNE BIO INC (INMB)?
The consensus rating for INMUNE BIO INC (INMB) is 76.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.